Bunge Global SA

Fundamentals6.0
Price Action6.0
News Sentiment7.0
AI Rating
7.0

Key Drivers

  • Thin margins
  • Elevated leverage
  • Uneven FCF

AI
AI Summary

7.0

Bunge's Viterra and specialty M&A reposition the company from a commodity trader to an integrated processed‑foods and logistics operator with a credible path to materially higher mid‑cycle margins and a $15 EPS target, but that upside is strictly conditional on delivering ~$341M of synergies, stabilizing free‑cash‑flow and avoiding leverage-driven funding stress. Investors should treat the recent buyback and multiple expansion as contingent signals—reward the stock only if quarterly evidence shows accelerating synergy capture, sustained positive FCF and falling net leverage; otherwise expect reversion to commodity cyclicality.

IntegrationUpside
ExecutionRisk
Leverage‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

6.0

Key Financial Insights:

  • Thin margins
  • Elevated leverage
  • Uneven FCF

BG generates substantial revenue and operating income but suffers from very thin margins, uneven annual free cash flow, and elevated leverage that constrain returns and flexibility.

Scale
Leverage

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Mild downtrend
  • Below SMA
  • Sharp pullback

Price slipped from about $121.95 to $118.15 over the last month, trading below its last-month 21-day SMA (~$120.7) with resistance near $125.90 and support around $116–$118 after a sharp one-day pullback that raises near-term downside risk.

bearish
watch
Support Level: $116–$118
Resistance Level: $125.90

Sharp one-day pullback into 2026-03-20 increasing near-term downside risk

Sentiment & News

7.0

Key News Insights:

  • EPS target
  • IFF acquisition
  • Debt issuance

Bunge in March 2026 announced a $15 mid‑cycle EPS growth plan to 2030, closed IFF's soy processing and ingredients business, issued $1.2bn of senior notes, and earned an ethics award — signaling concurrent strategic expansion, financing and reputation management.

Growth
CapitalMarkets

The acquisition and growth plan support longer‑term earnings upside while the $1.2bn note sale raises near‑term leverage and market sensitivity, so execution will determine equity performance